Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

WIN 2014 Symposium

23 - 24 Jun 2014
TBA, Paris, France
Industry view of targeted therapy combinations in oncology
Dr Susan Galbraith – AstraZeneca, Macclesfield, UK
Industry view of targeted therapy combinations in oncology ( Dr Susan Galbraith – AstraZeneca, Macclesfield, UK )
26 Jun 2014
Impact of biomarker-integrated approaches of targeted therapy for lung cancer el...
Prof Waun Ki Hong - University of Texas MD Anderson Cancer Center, Houston, USA
Impact of biomarker-integrated approaches of targeted therapy for lung cancer elimination ( Prof Waun Ki Hong - University of Texas MD Anderson Cancer Center, Houston, USA )
26 Jun 2014
Networking and collaborating across borders in sub-Saharan Africa
Dr Shubhra Ghosh - Project Director of Global Programs, MD Anderson Cancer Cent...
Networking and collaborating across borders in sub-Saharan Africa ( Dr Shubhra Ghosh -  Project Director of Global Programs, MD Anderson Cancer Centre, Houston, USA )
26 Jun 2014
Genomic complexity of metastatic disease and the conundrum of combinations
Prof Razelle Kurzrock - University of California, San Diego, USA
Genomic complexity of metastatic disease and the conundrum of combinations ( Prof Razelle Kurzrock - University of California, San Diego, USA )
26 Jun 2014
Complexity of intra- and inter-pathway loops in colon cancer and melanoma: Impli...
Prof René Bernards - Netherlands Cancer Institute, Amsterdam, The Netherlands
Complexity of intra- and inter-pathway loops in colon cancer and melanoma: Implications for targeted therapies ( Prof René Bernards - Netherlands Cancer Institute, Amsterdam, The Netherlands )
26 Jun 2014
WIN consortium as a basis for forming cross-border collaborations for improving ...
Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA
WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care ( Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA )
26 Jun 2014
Systems medicine approach to optimise drugs and drug combinations for individual...
Dr Olli Kallioniemi - University of Helsinki, Helsinki, Finland
Systems medicine approach to optimise drugs and drug combinations for individual AML patients ( Dr Olli Kallioniemi - University of Helsinki, Helsinki, Finland )
26 Jun 2014
Work of the WIN consortium and challenges of personalised cancer therapy
Prof John Mendelsohn - University of Texas MD Anderson Cancer Center, Houston, U...
Work of the WIN consortium and challenges of personalised cancer therapy ( Prof John Mendelsohn - University of Texas MD Anderson Cancer Center, Houston, USA )
26 Jun 2014
Tumour-infiltrating immune cells as classifiers and predictors of outcome
Dr Jérôme Galon - Laboratory of Integrative Cancer Immunology, Paris, France
Tumour-infiltrating immune cells as classifiers and predictors of outcome ( Dr Jérôme Galon - Laboratory of Integrative Cancer Immunology, Paris, France )
26 Jun 2014
Proactive P4 medicine making blood a window into health and disease
Prof Leroy Hood - Systems Biology, Seattle, USA
Proactive P4 medicine making blood a window into health and disease ( Prof Leroy Hood - Systems Biology, Seattle, USA )
26 Jun 2014
Molecular investigations of immune cells and tumour environment: The ovarian can...
Dr George Coukos - Ludwig Center for Cancer Research, Epalinges, Switzerland
Molecular investigations of immune cells and tumour environment: The ovarian cancer model ( Dr George Coukos - Ludwig Center for Cancer Research, Epalinges, Switzerland )
26 Jun 2014
Growing tissue stem cells into organoids and tumeroids: Predictive assay develop...
Prof Hans Clevers - Hubrecht Institute, Utrecht, The Netherlands
Growing tissue stem cells into organoids and tumeroids: Predictive assay development ( Prof Hans Clevers - Hubrecht Institute, Utrecht, The Netherlands )
26 Jun 2014
Combining immunological and targeted agents in melanoma
Dr Axel Hoos - GlaxoSmithKline, Collegeville, USA
Combining immunological and targeted agents in melanoma ( Dr Axel Hoos - GlaxoSmithKline, Collegeville, USA )
26 Jun 2014
Perspectives for effective cancer drug development: The EORTC SPECTA Initiative
Dr Denis Lacombe - EORTC, Brussels, Belgium
Perspectives for effective cancer drug development: The EORTC SPECTA Initiative ( Dr Denis Lacombe - EORTC, Brussels, Belgium )
26 Jun 2014
Cancer stem cells and malignant progression
Prof Rob Weinberg - Massachusetts Institute of Technology, Cambridge, USA
Cancer stem cells and malignant progression ( Prof Rob Weinberg - Massachusetts Institute of Technology, Cambridge, USA )
26 Jun 2014
Colorectal cancer screening and the EORTC SPECTA initiative
Dr Sabine Tejpar - University of Leuven, Leuven, Belgium
Colorectal cancer screening and the EORTC SPECTA initiative ( Dr Sabine Tejpar - University of Leuven, Leuven, Belgium )
26 Jun 2014
microRNA replacement in malignant pleural mesothelioma
Dr Glen Reid - The University of Sydney, Sydney, Australia
microRNA replacement in malignant pleural mesothelioma ( Dr Glen Reid - The University of Sydney, Sydney, Australia )
26 Jun 2014
Personalised cancer medicine using the human protein atlas and affibodies
Prof Mathias Uhlén - Royal Institute of Technology (KTH), Stockholm, Sweden
Personalised cancer medicine using the human protein atlas and affibodies ( Prof Mathias Uhlén - Royal Institute of Technology (KTH), Stockholm, Sweden )
26 Jun 2014
ARC Foundation's work and aims
Dr Jacques Raynaud - Foundation ARC pour la Recherche Cancer, Villejuif, France
ARC Foundation's work and aims ( Dr Jacques Raynaud - Foundation ARC pour la Recherche Cancer, Villejuif, France )
26 Jun 2014
IDH1 mutation in haemato-oncology
Dr Christof von Kalle - German Cancer Research Center (DKFZ), Heidelberg, German...
IDH1 mutation in haemato-oncology ( Dr Christof von Kalle - German Cancer Research Center (DKFZ), Heidelberg, Germany )
26 Jun 2014
EORTC fosters move towards tailored cancer treatment through the SPECTA initiati...
Prof Roger Stupp - President of the European Organization for Research and Treat...
EORTC fosters move towards tailored cancer treatment through the SPECTA initiative in colorectal cancer ( Prof Roger Stupp - President of the European Organization for Research and Treatment of Cancer (EORTC) )
26 Jun 2014
Novel drug targets and potential combinations in childhood brain tumours
Dr Stefan Pfister - German Cancer Research Center (DKFZ), Heidelberg, Germany
Novel drug targets and potential combinations in childhood brain tumours ( Dr Stefan Pfister - German Cancer Research Center (DKFZ), Heidelberg, Germany )
26 Jun 2014